Lupin gets US FDA tentative marketing approval for generic Xywav oral solution

Lupin gets US FDA tentative marketing approval for generic Xywav oral solution

By, Admin 14 October 2023

Global pharma major Lupin Limited (Lupin) has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for calcium, magnesium, potassium, and sodium oxybates oral solution, 0.5 g/mL, to market a generic equivalent of Xywav oral solution, 0.5 g/mL of Jazz Pharmaceuticals Ireland Limited. This product will be manufactured at Lupin’s Somerset facility in the US.

Lupin is exclusive first-to-file and may be eligible to receive a 180-day exclusivity period at product launch.

The net product sales for calcium, magnesium, potassium, and sodium oxybates oral solution (Xywav) were USD 958.4 million for the year ending December 2022 and USD 604.3 million for the first six months of 2023.

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the US, India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!